Precision medicine uses all available data for a particular patient to enable their best possible treatment and care. Molecular imaging contributes to this through the use of imaging agents which target specific biomarkers that are indicative of disease or response to therapy. Biomarkers are often proteins that are visible—and targetable—manifestations of a patient's genetic blueprint.

Contact the PI: Martin G. Pomper, M.D., Ph.D.